Bersiporocin

DB18017InvestigationalSmall molecule

Bersiporocin: Overview.

Mechanism: Pharmacologically active on Bifunctional glutamate/proline--tRNA ligase
Curator reviewed
Formula / weight: C₁₅H₁₉Cl₂N₃O · 328.24 g/mol (avg)
Also known as: (2r,3s)-2-(3-(4,5-dichloro-1h-benzo(d)imidazol-1-yl)propyl)piperidin-3-ol · 3-piperidinol, 2-(3-(4,5-dichloro-1h-benzimidazol-1-yl)propyl)-, (2r,3s)
Code names: DWN-12088

Resolves to

Compound

Structure

InChIKeyVXCNMWNXDDMFSX-YPMHNXCESA-NSMILESO[C@H]1CCCN[C@@H]1CCCN1C=NC2=C(Cl)C(Cl)=CC=C12

Targets

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Bersiporocin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.